Clinical Trials Directory

Trials / Completed

CompletedNCT02288585

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus

The Effect of a Low-fat Spread Enriched With Plant Sterol Esters on the Blood Lipid Profile of Subjects With Established Type 2 Diabetes Mellitus and Subjects at High Risk of Developing Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Unilever R&D · Industry
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Accepted

Summary

Double-blind, randomised, placebo-controlled, parallel group study with two intervention arms. The study will be conducted in 150 subjects and the primary objective is to show a fasting LDL-cholesterol and triglyceride lowering effect of plant sterols in subjects with established type 2 diabetes mellitus and subjects at high risk of developing type 2 diabetes.

Detailed description

The main aim of the study is to investigate the effect of plant sterols on fasting triglycerides and LDL-cholesterol concentrations. This study also aims to study the effect of plant sterols on fasting total cholesterol, HDL-cholesterol concentrations and Lipoprotein (a). Furthermore the effects of plant sterols on fasting blood glucose and insulin will be explored. At last, in a sub-group, at end of intervention the acute, chronic and acute upon chronic effect of plant sterols on postprandial blood lipids, glucose and insulin responses during a mixed meal challenge rich in fat and carbohydrates will be explored.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlant sterolsPlant sterols
DIETARY_SUPPLEMENTPlacebo productPlacebo product

Timeline

Start date
2014-10-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-11-11
Last updated
2017-01-19

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT02288585. Inclusion in this directory is not an endorsement.

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus (NCT02288585) · Clinical Trials Directory